I. D. de Boer

发表

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.

Toshiko Tanaka, S. Bandinelli, L. Ferrucci, 2012, JAMA.

NFAT5 and SLC4A10 Loci Associate with Plasma Osmolality.

M. P. Concas, Toshiko Tanaka, J. Murabito, 2017, Journal of the American Society of Nephrology : JASN.

DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes

Angelo J. Canty, J. Keith Jones, A. Paterson, 2020, Clinical Epigenetics.

Modelling kidney disease using ontology: insights from the Kidney Precision Medicine Project

Lucy Lu Wang, Peter N. Robinson, A. Diehl, 2020, Nature Reviews Nephrology.

Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.

B. Kestenbaum, I. D. de Boer, J. Himmelfarb, 2015, Journal of diabetes and its complications.

Edinburgh Research Explorer Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function

Tom R. Gaunt, Andrew D. Johnson, Nicholette D. Palmer, 2022 .

Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Dietary Acid Load is Associated With Serum Bicarbonate but not Insulin Sensitivity in Chronic Kidney Disease.

B. Kestenbaum, I. D. de Boer, J. Himmelfarb, 2016, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Nephrology at a Crossroads.

I. D. de Boer, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: Evidence-based advances in monitoring and treatment.

K. Khunti, J. Chan, I. D. de Boer, 2020, Kidney international.

Association of oral calcitriol with improved survival in nondialyzed CKD.

B. Kestenbaum, I. D. de Boer, K. Rudser, 2008, Journal of the American Society of Nephrology : JASN.

Fracture risk after parathyroidectomy among chronic hemodialysis patients.

B. Kestenbaum, I. D. de Boer, K. Rudser, 2007, Journal of the American Society of Nephrology : JASN.

The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease

B. Kestenbaum, Gregory Levin, C. Robinson-Cohen, 2012, Kidney international.

Urine albumin-to-creatinine ratio: what's in a number?

B. Kestenbaum, I. D. de Boer, 2010, Journal of the American Society of Nephrology : JASN.

Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients.

I. D. de Boer, K. Muczynski, C. Davis, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Genome-wide association study of kidney function decline in individuals of European descent

Andrew D. Johnson, Audrey Y. Chu, F. Kronenberg, 2014, Kidney international.

Pragmatic Clinical Trials in CKD: Opportunities and Challenges.

Miguel A. Vazquez, I. D. de Boer, S. Navaneethan, 2016, Journal of the American Society of Nephrology : JASN.

Standardised Outcomes in Nephrology – Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy

I. D. de Boer, A. Levin, A. Levey, 2021, Trials.

Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2018, Journal of the American Society of Nephrology : JASN.

The association of calcium supplementation and incident cardiovascular events in the Multi-ethnic Study of Atherosclerosis (MESA).

M. Szklo, I. D. de Boer, D. Siscovick, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Physical activity and change in estimated GFR among persons with CKD.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2014, Journal of the American Society of Nephrology : JASN.

Kidney Disease and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

I. D. de Boer, 2013, Diabetes Care.

Physical activity and metabolic health in chronic kidney disease: a cross-sectional study

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2016, BMC Nephrology.

The kidney's role in systemic metabolism-still much to learn.

I. D. de Boer, K. Utzschneider, 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Insulin resistance in CKD: a step closer to effective evaluation and treatment

I. D. de Boer, R. Mehrotra, 2014, Kidney international.

Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease

B. Kestenbaum, I. D. de Boer, A. Hoofnagle, 2012, Kidney international.

Glomerular filtration rate and albuminuria: twin manifestations of nephropathy in diabetes.

I. D. de Boer, M. Steffes, 2007, Journal of the American Society of Nephrology : JASN.

Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes.

I. D. de Boer, I. Hirsch, K. Tuttle, 2022, Journal of diabetes and its complications.

Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association

I. D. de Boer, M. Vaduganathan, V. Bhalla, 2020, Circulation.

The expanding résumé of SGLT2 inhibitors.

I. D. de Boer, 2019, The lancet. Diabetes & endocrinology.

SGLT2 Inhibitors-Sweet Success for Diabetic Kidney Disease?

I. D. de Boer, S. Kahn, 2017, Journal of the American Society of Nephrology : JASN.

Validated SNPs for eGFR and their associations with albuminuria.

A. Köttgen, C. Fox, I. D. de Boer, 2012, Human molecular genetics.

Should glucose-sparing prescriptions be expected to reduce the cardiovascular risk of peritoneal dialysis patients?

I. D. de Boer, R. Mehrotra, 2013, Journal of the American Society of Nephrology : JASN.

Fibroblast Growth Factor 23 and Long-Term Cardiac Function

Sanjiv J. Shah, Ravi B. Patel, B. Kestenbaum, 2020, Circulation. Cardiovascular imaging.

Associations of innate and adaptive immune cell subsets with incident type 2 diabetes risk: the MESA study.

I. D. de Boer, B. Psaty, C. Sitlani, 2020, The Journal of clinical endocrinology and metabolism.

Impact of race on the association of mineral metabolism with heart failure: the Multi-Ethnic Study of Atherosclerosis.

M. Szklo, B. Kestenbaum, C. Robinson-Cohen, 2019, The Journal of clinical endocrinology and metabolism.

Fibroblast Growth Factor-23, Heart Failure Risk, and Renin–Angiotensin–Aldosterone-System Blockade in Hypertension: The MESA Study

C. Yancy, M. Szklo, B. Kestenbaum, 2018, American journal of hypertension.

Association of High‐Density Lipoprotein Particles and High‐Density Lipoprotein Apolipoprotein C‐III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi‐Ethnic Study of Atherosclerosis

I. D. de Boer, S. Mora, R. McClelland, 2019, Journal of the American Heart Association.

Relation of Serum Vitamin D to Risk of Mitral Annular and Aortic Valve Calcium (from the Multi-Ethnic Study of Atherosclerosis).

M. Budoff, B. Kestenbaum, I. D. de Boer, 2017, The American journal of cardiology.

Serum vitamin D and sex hormones levels in men and women: The Multi-Ethnic Study of Atherosclerosis (MESA).

I. D. de Boer, D. Siscovick, E. Guallar, 2017, Maturitas.

Associations of Serum 25-Hydroxyvitamin D With Hemostatic and Inflammatory Biomarkers in the Multi-Ethnic Study of Atherosclerosis.

B. Kestenbaum, I. D. de Boer, M. Cushman, 2016, The Journal of clinical endocrinology and metabolism.

Parathyroid Hormone and the Use of Diuretics and Calcium‐Channel Blockers: The Multi‐Ethnic Study of Atherosclerosis

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Associations of Circulating Lymphocyte Subpopulations with Type 2 Diabetes: Cross-Sectional Results from the Multi-Ethnic Study of Atherosclerosis (MESA)

R. Kronmal, I. D. de Boer, B. Psaty, 2015, PloS one.

Vitamin D metabolites and bone mineral density: The multi-ethnic study of atherosclerosis.

M. Budoff, B. Kestenbaum, C. Robinson-Cohen, 2015, Bone.

Mineral metabolism and the right ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA).

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association of fibroblast growth factor-23 with arterial stiffness in the Multi-Ethnic Study of Atherosclerosis.

B. Kestenbaum, I. D. de Boer, M. Shlipak, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Serum phosphate is associated with aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA).

M. Budoff, B. Kestenbaum, I. D. de Boer, 2014, Atherosclerosis.

Influence of urine creatinine concentrations on the relation of albumin-creatinine ratio with cardiovascular disease events: the Multi-Ethnic Study of Atherosclerosis (MESA).

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

A. D. Diez Roux, B. Kestenbaum, I. D. de Boer, 2012, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis.

A. Sharrett, M. Szklo, B. Astor, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA).

B. Astor, B. Kestenbaum, I. D. de Boer, 2008, Atherosclerosis.

Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis.

B. Astor, B. Kestenbaum, I. D. de Boer, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes

Sylvia Stracke, Christian Gieger, Joshua C. Denny, 2015, Diabetes.

Variation in oral calcitriol response in patients with stages 3-4 CKD.

B. Kestenbaum, Gregory Levin, I. D. de Boer, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The effect of calcium plus vitamin D supplementation on the risk of venous thromboembolism

J. Manson, A. LaCroix, Karen C Johnson, 2015, Thrombosis and Haemostasis.

Markers of kidney disease and risk of subclinical and clinical heart failure in African Americans: the Jackson Heart Study.

B. Kestenbaum, I. D. de Boer, N. Bansal, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Retinal Capillary Nonperfusion on OCT-Angiography and Its Relationship to Kidney Function in Patients with Diabetes

Ruikang K. Wang, I. D. de Boer, Qinqin Zhang, 2020, Journal of ophthalmology.

Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III).

B. Kestenbaum, I. D. de Boer, T. Rue, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

PERL in Diabetes Study : A Randomized Double-Blinded Trial of Allopurinol d Rationale , Design , and Baseline Data

J. McGill, I. D. de Boer, A. Galecki, 2019 .

Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.

J. Manson, J. Buring, R. Glynn, 2018, Contemporary clinical trials.

Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline

K. Khunti, J. Chan, I. D. de Boer, 2020, Annals of Internal Medicine.

Liraglutide and Renal Outcomes in Type 2 Diabetes.

I. D. de Boer, 2017, The New England journal of medicine.

Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis.

I. D. de Boer, A. Hoofnagle, J. Brunzell, 2015, Journal of proteome research.

Screening for chronic kidney disease

I. D. de Boer, B. Kiberd, U. Patel, 2010, BMJ : British Medical Journal.

The effect of combined calcium and cholecalciferol supplementation on bone mineral density in elderly women with moderate chronic kidney disease

I. D. de Boer, M. Chonchol, G. Targher, 2011, Clinical nephrology.

Diabetes and CKD in the United States Population, 2009-2014.

P. Heagerty, B. Kestenbaum, C. Robinson-Cohen, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Liraglutide and Renal Outcomes in Type 2 Diabetes.

I. D. de Boer, 2017, The New England journal of medicine.

Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease.

B. Kestenbaum, I. D. de Boer, A. Hoofnagle, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Anna C. Porter, I. D. de Boer, M. Wolf, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Impaired vitamin D metabolism in CKD.

I. D. de Boer, Cortney Bosworth, 2013, Seminars in nephrology.

The Surging Tide of Diabetes: Implications for Nephrology.

I. D. de Boer, M. Afkarian, K. Tuttle, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Soluble ST2 and Galectin-3 and Progression of CKD

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2018, Kidney international reports.

Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis.

B. Kestenbaum, I. D. de Boer, K. Kalantar-Zadeh, 2015, Journal of the American Society of Nephrology : JASN.

Growth Differentiation Factor-15 and Risk of CKD Progression.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2017, Journal of the American Society of Nephrology : JASN.

Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients

B. Kestenbaum, I. D. de Boer, W. Ju, 2017, EBioMedicine.

Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical Trial.

I. D. de Boer, G. Bakris, M. Currie, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Kidney function is associated with an altered protein composition of high-density lipoprotein.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2017, Kidney international.

Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease.

I. D. de Boer, J. Shults, B. Zemel, 2013, The Journal of clinical endocrinology and metabolism.

Temporal Relationship of Glycemia With Cardiac Arrhythmias in Patients With Type 2 Diabetes and CKD.

I. D. de Boer, I. Hirsch, N. Bansal, 2020, American Journal of Kidney Diseases.

Triglyceride-Rich Lipoproteins, Apolipoproteins, and Atherosclerotic Cardiovascular Events Among Patients with Diabetes Mellitus and End-Stage Renal Disease on Hemodialysis.

I. D. de Boer, W. März, H. Scharnagl, 2021, The American journal of cardiology.

Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.

I. D. de Boer, J. Emberson, C. Baigent, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease

I. D. de Boer, I. Hirsch, R. Little, 2020, Diabetes Care.

Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry.

Frederick G. Strathmann, I. D. de Boer, A. Hoofnagle, 2012, Clinical chemistry.

Cholecalciferol in chronic dialysis patients: not strong enough?

B. Kestenbaum, I. D. de Boer, 2013, Clinical journal of the American Society of Nephrology : CJASN.

A reference tissue atlas for the human kidney

Rachel S. G. Sealfon, Michael P. Rose, O. Troyanskaya, 2021, bioRxiv.

Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study.

I. D. de Boer, A. Schwartz, M. Rubin, 2022, The lancet. Diabetes & endocrinology.

Blood pressure, antihypertensive medication use, and risk of erectile dysfunction in men with type I diabetes

Mary K. Oerline, I. D. de Boer, R. Dunn, 2019, Journal of hypertension.

Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis

I. D. de Boer, W. Ju, S. Hallan, 2018, Kidney international reports.

Integrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine Project.

Celia P. Corona-Villalobos, I. D. de Boer, P. Appelbaum, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Histopathologic and Clinical Features in Patients with Diabetes and Kidney Disease.

I. D. de Boer, C. Alpers, L. Zelnick, 2020, Kidney360.

Renal Clearance of Mineral Metabolism Biomarkers.

B. Kestenbaum, I. D. de Boer, E. Rhee, 2016, Journal of the American Society of Nephrology : JASN.

Effects of a high-protein diet on regulation of phosphorus homeostasis.

B. Kestenbaum, I. D. de Boer, A. Hoofnagle, 2013, The Journal of clinical endocrinology and metabolism.

Potassium Measures and Their Associations with Glucose and Diabetes Risk: The Multi-Ethnic Study of Atherosclerosis (MESA)

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2016, PloS one.

Potassium and glucose measures in older adults: the Cardiovascular Health Study.

D. Mozaffarian, I. D. de Boer, D. Siscovick, 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

Impaired skeletal muscle mitochondrial bioenergetics and physical performance in chronic kidney disease.

Lucas R. Smith, B. Kestenbaum, I. D. de Boer, 2020, JCI insight.

Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.

I. D. de Boer, J. Lachin, P. Cleary, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Galectin-3 and Soluble ST2 and Kidney Function Decline in Older Adults: The Cardiovascular Health Study (CHS).

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2016, American Journal of Kidney Diseases.

A New Chapter for Diabetic Kidney Disease.

I. D. de Boer, 2017, The New England journal of medicine.

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

Mark E Molitch, Irl B Hirsch, Kamyar Kalantar-Zadeh, 2014, Diabetes Care.

Association of Genetically Predicted Fibroblast Growth Factor-23 with Heart Failure

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2022, Clinical journal of the American Society of Nephrology : CJASN.

Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study.

B. Kestenbaum, I. D. de Boer, A. Hoofnagle, 2020, Journal of the American Society of Nephrology : JASN.

Vitamin D in chronic kidney disease: is the jury in?

B. Kestenbaum, I. D. de Boer, 2008, Kidney international.

Albuminuria, the HDL (High-Density Lipoprotein) Proteome, and Coronary Artery Calcification in Type 1 Diabetes Mellitus.

I. D. de Boer, J. Snell-Bergeon, J. Himmelfarb, 2019, Arteriosclerosis, thrombosis, and vascular biology.

SGLT2 Inhibitors in Diabetic Kidney Disease.

I. D. de Boer, S. Zoungas, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Association of body mass index with peripheral arterial disease in older adults: the Cardiovascular Health Study.

I. D. de Boer, D. Siscovick, A. Newman, 2011, American journal of epidemiology.

Vitamin D insufficiency.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2011, The New England journal of medicine.

CUBN is a gene locus for albuminuria.

Sylvia Stracke, Ming-Huei Chen, Luigi Ferrucci, 2011, Journal of the American Society of Nephrology : JASN.

Invited commentary: Quantifying salt in urine--a complex solution.

B. Kestenbaum, I. D. de Boer, 2013, American journal of epidemiology.

Kidney Function in Patients With Type 2 Diabetes After Vitamin D Supplementation-Reply.

J. Manson, I. D. de Boer, L. Zelnick, 2020, JAMA.

Vitamin D, parathyroid hormone, glucose metabolism and incident diabetes in the multiethnic study of atherosclerosis

B. Kestenbaum, I. D. de Boer, A. Bertoni, 2022, BMJ Open Diabetes Research & Care.

Associations of Dietary Intake with Urinary Melamine and Derivative Concentrations among Children in the GAPPS Cohort

I. D. de Boer, J. Flynn, K. Kannan, 2022, International journal of environmental research and public health.

KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.

K. Khunti, I. D. de Boer, C. Wanner, 2022, Kidney international.

Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence.

K. Khunti, I. D. de Boer, M. Tonelli, 2022, Kidney international.

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

Connie M. Rhee, K. Khunti, I. D. de Boer, 2022, Diabetes care.

Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population: The Multi-Ethnic Study of Atherosclerosis

J. Polak, B. Kestenbaum, C. Robinson-Cohen, 2014, Circulation. Heart failure.

Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels

Peter K. Joshi, P. O’Reilly, M. Jarvelin, 2018, Nature Communications.

A diet high in low-fat dairy products lowers diabetes risk in postmenopausal women.

J. Manson, I. D. de Boer, B. Howard, 2011, The Journal of nutrition.

Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes

L. Aiello, I. D. de Boer, W. Tamborlane, 2021, Diabetes Care.

Biomarkers of tubulointerstitial damage and function in type 1 diabetes

A. Paterson, B. Zinman, I. D. de Boer, 2017, BMJ Open Diabetes Research & Care.

Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury

Brandon G. Ginley, Briana A. Santo, B. Kestenbaum, 2022, PloS one.

Comparative Effects of Cholecalciferol and Calcitriol on Circulating Markers of CKD Mineral Bone Disorder: A Randomized Clinical Trial.

B. Kestenbaum, I. D. de Boer, M. Chonchol, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Recalibration of 24,25-Dihydroxyvitamin D3 Results Based on NIST Standard Reference Material 972a.

I. D. de Boer, A. Hoofnagle, Thomas J. Laha, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Proteinuria and lipoprotein lipase activity in Miniature Schnauzer dogs with and without hypertriglyceridemia.

I. D. de Boer, J. Brunzell, K. Hinchcliff, 2016, Veterinary journal.

Circulating 25-hydroxyvitamin D is associated with insulin resistance cross-sectionally but not longitudinally in older adults: The Cardiovascular Health Study.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2013, Metabolism: clinical and experimental.

Renal ApoA-1 amyloidosis with Glu34Lys mutation and intra-amyloid lipid accumulation.

Daniel Y. Lam, I. D. de Boer, R. Nicosia, 2014, Journal of the American Society of Nephrology : JASN.

Effects of Vitamin D3 Supplementation on Cardiovascular and Cancer Outcomes by eGFR in VITAL

J. Manson, N. Cook, J. Buring, 2022, Kidney360.

CKD and Muscle Mitochondrial Energetics.

B. Kestenbaum, I. D. de Boer, J. Himmelfarb, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Circulating differentiated and senescent lymphocyte subsets and incident diabetes risk in older adults: The Cardiovascular Health Study

I. D. de Boer, B. Psaty, C. Sitlani, 2022, Endocrinology, diabetes & metabolism.

A high ankle brachial index is associated with greater left ventricular mass MESA (Multi-Ethnic Study of Atherosclerosis).

D. Bluemke, I. D. de Boer, D. Siscovick, 2010, Journal of the American College of Cardiology.

Early Glomerular Hyperfiltration and Long-Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience.

A. Paterson, B. Zinman, I. D. de Boer, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Temporal trends in the prevalence of diabetic kidney disease in the United States.

Patrick J Heagerty, Noel S Weiss, Jonathan Himmelfarb, 2011, JAMA.

Present and future directions in diabetic kidney disease.

I. D. de Boer, M. Kretzler, R. Pop-Busui, 2022, Journal of diabetes and its complications.

Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2011, The Journal of clinical endocrinology and metabolism.

Transethnic Evaluation Identifies Low-Frequency Loci Associated With 25-Hydroxyvitamin D Concentrations

Nicholette D. Palmer, M. Nalls, J. Pankow, 2018, The Journal of clinical endocrinology and metabolism.

Polymorphic Human Sulfotransferase 2A1 Mediates the Formation of 25-Hydroxyvitamin D3-3-O-Sulfate, a Major Circulating Vitamin D Metabolite in Humans

I. D. de Boer, T. Thornton, E. Schuetz, 2018, Drug Metabolism and Disposition.

Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - a post-hoc analysis of the PERL study.

J. McGill, I. D. de Boer, T. Hansen, 2022, Diabetes research and clinical practice.

Triglyceride content of lipoprotein subclasses and kidney hemodynamic function and injury in adolescents with type 1 diabetes.

I. D. de Boer, R. Wadwa, D. Gordin, 2022, Journal of diabetes and its complications.

Chronic kidney disease—a challenge for all ages.

I. D. de Boer, 2012, JAMA.

Biomarkers of Vitamin D Metabolism and Hip and Vertebral Fracture Risk: The Multi‐Ethnic Study of Atherosclerosis

B. Kestenbaum, I. D. de Boer, M. Criqui, 2022, JBMR plus.

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

I. D. de Boer, G. Bakris, I. Hirsch, 2014, Diabetes Care.

Glycerol-3-phosphate is a FGF23 regulator derived from the injured kidney.

D. Leaf, B. Kestenbaum, I. D. de Boer, 2020, The Journal of clinical investigation.

Association between adiposity in midlife and older age and risk of diabetes in older adults.

D. Mozaffarian, I. D. de Boer, D. Siscovick, 2010, JAMA.

Serum Bicarbonate Is Associated with Heart Failure in the Multi-Ethnic Study of Atherosclerosis

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2016, American Journal of Nephrology.

Kidney disease and increased mortality risk in type 2 diabetes.

B. Kestenbaum, I. D. de Boer, I. Hirsch, 2013, Journal of the American Society of Nephrology : JASN.

Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-living Individuals Chs (cardiovascular Health Study)

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2022 .

Diabetes and Hypertension: A Position Statement by the American Diabetes Association

I. D. de Boer, G. Bakris, S. Bangalore, 2017, Diabetes Care.

Meta-analysis across Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium provides evidence for an association of serum vitamin D with pulmonary function

M. Fornage, A. Hofman, J. Pankow, 2018, British Journal of Nutrition.

Large Meta-Analysis Provides Evidence for an Association of Serum Vitamin D with Pulmonary Function

M. Fornage, A. Hofman, J. Pankow, 2017, bioRxiv.

SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function.

Nathan A. Bihlmeyer, Janina M. Jeff, Audrey Y. Chu, 2017, Journal of the American Society of Nephrology : JASN.

Common genetic variants associate with serum phosphorus concentration.

C. Gieger, A. Hofman, A. Uitterlinden, 2010, Journal of the American Society of Nephrology : JASN.

Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies

J. Gallacher, J. Danesh, O. Franco, 2018, European heart journal.

Renal outcomes in patients with type 1 diabetes and macroalbuminuria.

B. Zinman, I. D. de Boer, J. Lachin, 2014, Journal of the American Society of Nephrology : JASN.

Multi-Scalar Data Integration Links Glomerular Angiopoietin-Tie Signaling Pathway Activation With Progression of Diabetic Kidney Disease

I. D. de Boer, Min Chen, S. Waikar, 2021, medRxiv.

Rationale and design of the Kidney Precision Medicine Project.

Michael T. Eadon, N. Hacohen, O. Troyanskaya, 2021, Kidney international.

Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.

B. Kestenbaum, I. D. de Boer, N. Weiss, 2007, Journal of the American Society of Nephrology : JASN.

A prospective study of frailty in nephrology-referred patients with CKD.

B. Kestenbaum, Gregory Levin, C. Robinson-Cohen, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.

Angelo J. Canty, M. McCarthy, A. Paterson, 2019, Journal of the American Society of Nephrology : JASN.

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association

G. Bray, R. Eckel, C. Fox, 2015, Diabetes Care.

Dietary Phosphorus, Blood Pressure, and Incidence of Hypertension in the Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis

A. Folsom, L. Chambless, D. Jacobs, 2010, Hypertension.

25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2009, Journal of the American Society of Nephrology : JASN.

Obesity and change in estimated GFR among older adults.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Chronic kidney disease, insulin resistance, and incident diabetes in older adults.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Measurement of insulin resistance in chronic kidney disease

I. D. de Boer, H. Pham, K. Utzschneider, 2011, Current opinion in nephrology and hypertension.

The Relation of Serum Potassium Concentration with Cardiovascular Events and Mortality in Community-Living Individuals.

B. Kestenbaum, I. D. de Boer, B. Psaty, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Genetic Association for Renal Traits among Participants of African Ancestry Reveals New Loci for Renal Function

M. Nalls, C. Rotimi, A. Adeyemo, 2011, PLoS genetics.

Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.

P. Heagerty, I. D. de Boer, N. Weiss, 2016, JAMA.

Use of Electronic Health Data to Estimate Heart Failure Events in a Population-Based Cohort with CKD.

I. D. de Boer, B. Psaty, N. Bansal, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses

J. Gallacher, J. Danesh, J. Boer, 2021, The lancet. Diabetes & endocrinology.

Genetic Variants Associated with Circulating Parathyroid Hormone.

Daniel L. Koller, J. Pankow, A. Paterson, 2017, Journal of the American Society of Nephrology : JASN.

Genetic and environmental factors are associated with serum 25-hydroxyvitamin D concentrations in older African Americans.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2015, The Journal of nutrition.

Vitamin D deficiency: consequence or cause of CKD?

I. D. de Boer, R. Thadhani, 2013, Clinical journal of the American Society of Nephrology : CJASN.

GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D‐Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes

I. D. de Boer, H. Feldman, A. Hoofnagle, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study.

B. Kestenbaum, Gregory Levin, I. D. de Boer, 2011, American journal of epidemiology.

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

M. Budoff, R. Eckel, I. D. de Boer, 2021, Journal of diabetes and its complications.

The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2017, Annals of Internal Medicine.

Risk Factors for Kidney Disease in Type 1 Diabetes

A. Paterson, I. D. de Boer, W. Tamborlane, 2019, Diabetes Care.

Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.

B. Zinman, I. D. de Boer, L. Hubbard, 2011, Archives of internal medicine.

Relations of Dietary Magnesium Intake to Biomarkers of Inflammation and Endothelial Dysfunction in an Ethnically Diverse Cohort of Postmenopausal Women

I. D. de Boer, F. Tylavsky, Simin Liu, 2009, Diabetes Care.

Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study

I. D. de Boer, D. Siscovick, A. Newman, 2012, Vascular medicine.

Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

B. Zinman, R. Eckel, C. Fox, 2014, Circulation.

Validation of the 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio as a biomarker of 25-hydroxyvitamin D3 clearance

B. Kestenbaum, I. D. de Boer, A. Hoofnagle, 2021, The Journal of Steroid Biochemistry and Molecular Biology.

Vitamin D Metabolic Ratio and Risks of Death and CKD Progression

A. Go, Mahboob Rahman, B. Kestenbaum, 2019, Kidney international reports.

Association of Vitamin D Metabolites With Arterial Function in the Hemodialysis Fistula Maturation Study.

G. Beck, A. Cheung, B. Kestenbaum, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis.

M. Budoff, B. Kestenbaum, Gregory Levin, 2013, The American journal of clinical nutrition.

Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials

I. D. de Boer, R. Jorde, W. Janssens, 2012, Scandinavian journal of infectious diseases.

Vitamin D, parathyroid hormone, and cardiovascular events among older adults.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2011, Journal of the American College of Cardiology.

Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy.

I. D. de Boer, B. Rovin, S. Waikar, 2017, Clinical Chemistry.

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.

J. McGill, I. D. de Boer, A. Galecki, 2020, The New England journal of medicine.

Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA).

D. Jacobs, B. Kestenbaum, I. D. de Boer, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly.

I. D. de Boer, D. Siscovick, M. Shlipak, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Insulin Resistance, Cystatin C, and Mortality Among Older Adults

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2012, Diabetes Care.

The risk of infection-related hospitalization with decreased kidney function.

Lorien S. Dalrymple, B. Kestenbaum, I. D. de Boer, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Glucose, insulin, and incident hypertension in the multi-ethnic study of atherosclerosis.

D. Jacobs, B. Kestenbaum, Gregory Levin, 2010, American journal of epidemiology.

Differences in Kidney Function and Incident Hypertension: The Multi-Ethnic Study of Atherosclerosis

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2008, Annals of Internal Medicine.

Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study).

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2009, Journal of the American College of Cardiology.

Cystatin C, Albuminuria, and Mortality Among Older Adults With Diabetes

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2009, Diabetes Care.

Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2009, Clinical journal of the American Society of Nephrology : CJASN.

25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III).

B. Kestenbaum, I. D. de Boer, N. Weiss, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association

B. Zinman, R. Eckel, C. Fox, 2014, Diabetes Care.

Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).

Connie M. Rhee, K. Khunti, I. D. de Boer, 2022, Kidney international.

Cystatin C identifies chronic kidney disease patients at higher risk for complications.

I. D. de Boer, D. Siscovick, A. Levey, 2011, Journal of the American Society of Nephrology : JASN.

NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.

Lorien S. Dalrymple, B. Kestenbaum, I. D. de Boer, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Adverse effects of systemic glucose absorption with peritoneal dialysis: how good is the evidence?

I. D. de Boer, J. Himmelfarb, R. Mehrotra, 2013, Current opinion in nephrology and hypertension.

Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.

I. D. de Boer, M. Wolf, H. Feldman, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2014, Atherosclerosis.

Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2013, Atherosclerosis.

Alteration of HDL Protein Composition with Hemodialysis Initiation.

G. Beck, B. Kestenbaum, C. Robinson-Cohen, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.

Mark E Molitch, John M Lachin, Wanjie Sun, 2011, The New England journal of medicine.

Fetuin-A and Risk of Diabetes Independent of Liver Fat Content: The Multi-Ethnic Study of Atherosclerosis

M. Budoff, I. D. de Boer, D. Siscovick, 2017, American journal of epidemiology.

A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.

I. D. de Boer, J. Himmelfarb, M. Afkarian, 2015, Journal of proteome research.

Laurie Quinn, Sherita Hill Golden, Prakash Deedwania, 2015, Circulation.

Hemoglobin A1c and Arterial and Ventricular Stiffness in Older Adults

L. Kuller, I. D. de Boer, D. Siscovick, 2012, PloS one.

Fetuin-A is inversely associated with coronary artery calcification in community-living persons: the Multi-Ethnic Study of Atherosclerosis.

M. Budoff, B. Kestenbaum, I. D. de Boer, 2012, Clinical chemistry.

Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.

M. Pencina, I. D. de Boer, M. Wolf, 2017, Journal of the American Society of Nephrology : JASN.

The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease.

I. D. de Boer, G. Chertow, Chi-yuan Hsu, 2002, Journal of the American Society of Nephrology : JASN.

Differences in proximal tubular solute clearance across common etiologies of chronic kidney disease.

B. Kestenbaum, I. D. de Boer, A. Hoofnagle, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study

B. Zinman, I. D. de Boer, J. Lachin, 2010, Diabetes Care.

Alcohol consumption and kidney function decline in the elderly: alcohol and kidney disease.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine Project.

I. D. de Boer, S. Waikar, P. Appelbaum, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2015, The Journal of clinical endocrinology and metabolism.

Dual Renin-Angiotensin-Aldosterone System Blockade for Diabetic Kidney Disease

I. D. de Boer, R. Pichler, 2010, Current diabetes reports.

Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2013, JAMA.

Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis.

Ryung S. Kim, M. Budoff, B. Kestenbaum, 2019, Atherosclerosis.

Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease

M. Szklo, I. D. de Boer, R. McClelland, 2018, Heart.

Serum 25-Hydroxyvitamin D Concentration and Risk for Major Clinical Disease Events in a Community-Based Population of Older Adults

B. Kestenbaum, Gregory Levin, C. Robinson-Cohen, 2012, Annals of Internal Medicine.

Chronic Kidney Disease, Plasma Lipoproteins, and Coronary Artery Calcium Incidence: The Multi-Ethnic Study of Atherosclerosis

M. Szklo, B. Astor, I. D. de Boer, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Mortality Associated with Metformin Versus Sulfonylurea Initiation: A Cohort Study of Veterans with Diabetes and Chronic Kidney Disease

I. D. de Boer, E. Boyko, N. Smith, 2018, Journal of General Internal Medicine.

Effect of Extended Release Niacin on Cardiovascular Events and Kidney Function in Chronic Kidney Disease: A Post-Hoc Analysis of the AIM-HIGH Trial

I. D. de Boer, W. Boden, J. Ix, 2014, Kidney international.

Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2011, Journal of the American College of Cardiology.

Serum Calcification Propensity and Clinical Events in CKD.

A. Go, I. D. de Boer, H. Feldman, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Genome-wide association study of diabetic kidney disease highlights biology involved in renal basement membrane collagen

Angelo J. Canty, M. McCarthy, A. Paterson, 2018, bioRxiv.

Urinary Creatinine Excretion Rate and Mortality in Persons With Coronary Artery Disease: The Heart and Soul Study

I. D. de Boer, M. Criqui, M. Shlipak, 2010, Circulation.

Association of omega 3 polyunsaturated fatty acids with incident chronic kidney disease: pooled analysis of 19 cohorts

Toshiko Tanaka, S. Bandinelli, L. Ferrucci, 2023, BMJ.

Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus.

B. Kestenbaum, I. D. de Boer, N. Weiss, 2008, Archives of internal medicine.

Chronic Kidney Disease is Associated With Attenuated Plasma Metabolome Response to Oral Glucose Tolerance Testing

Brian J. Bennett, L. Smith, I. D. de Boer, 2022, medRxiv.

Longitudinal changes in estimated and measured GFR in type 1 diabetes.

B. Zinman, I. D. de Boer, J. Lachin, 2014, Journal of the American Society of Nephrology : JASN.

Original Report: Patient-oriented, Translational Research Association between Dietary Sodium and Potassium Intake with Chronic Kidney Disease in Us Adults: a Cross-sectional Study

I. D. de Boer, S. Sharma, M. Chonchol, 2022 .

Risk Factors for Rapid Kidney Function Decline Among African Americans: The Jackson Heart Study (JHS).

N. Powe, B. Kestenbaum, C. Robinson-Cohen, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association of Obesity and Kidney Function Decline among Non-Diabetic Adults with eGFR > 60 ml/min/1.73m2: Results from the Multi-Ethnic Study of Atherosclerosis (MESA)

I. D. de Boer, D. Siscovick, M. Shlipak, 2013, Open journal of endocrine and metabolic diseases.

Body mass index is associated with increased creatinine clearance by a mechanism independent of body fat distribution.

Edward J Boyko, I. D. de Boer, S. Kahn, 2009, The Journal of clinical endocrinology and metabolism.

Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart Study.

B. Kestenbaum, I. D. de Boer, N. Bansal, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Physical activity and rapid decline in kidney function among older adults.

Lorien S. Dalrymple, D. Mozaffarian, B. Kestenbaum, 2009, Archives of internal medicine.

The association of glycated hemoglobin with mortality and ESKD among persons with diabetes and chronic kidney disease.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2019, Journal of diabetes and its complications.

Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.

I. D. de Boer, M. Shlipak, J. Ix, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort.

M. Budoff, I. D. de Boer, Dong Li, 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Prevalence of Hypertension and Cardiovascular Risk According to Blood Pressure Thresholds Used for Diagnosis

I. D. de Boer, N. Bansal, L. Zelnick, 2018, Hypertension.

Biomarkers of Key Biological Pathways in CVD.

Lori B Daniels, Nancy Swords Jenny, Russell P Tracy, 2016, Global heart.

Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes

I. D. de Boer, J. Lamprea-Montealegre, 2018, Diabetes Care.

Association between physical performance and all-cause mortality in CKD.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2013, Journal of the American Society of Nephrology : JASN.

eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.

E. Benjamin, B. Kestenbaum, C. Robinson-Cohen, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies

Lorien S. Dalrymple, B. Kestenbaum, C. Robinson-Cohen, 2016, JAMA cardiology.

Vitamin D and glucose metabolism in chronic kidney disease

I. D. de Boer, 2008, Current opinion in nephrology and hypertension.

Relationship Between Chronic Kidney Disease, Glucose Homeostasis, and Plasma Osteocalcin Carboxylation and Fragmentation.

S. Booth, B. Kestenbaum, I. D. de Boer, 2020, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Validity of predictive equations for 24-h urinary potassium excretion based on timing of spot urine collection among adults: the MESA and CARDIA Urinary Sodium Study and NHANES Urinary Sodium Calibration Study.

I. D. de Boer, C. Loria, M. Cogswell, 2018, The American journal of clinical nutrition.

Metabolic Clusters and Outcomes in Older Adults: The Cardiovascular Health Study

I. D. de Boer, D. Siscovick, A. Fitzpatrick, 2018, Journal of the American Geriatrics Society.

Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study.

I. D. de Boer, D. Siscovick, J. Gottdiener, 2016, Metabolism: clinical and experimental.

Vitamin D, Parathyroid Hormone, and Sudden Cardiac Death: Results From the Cardiovascular Health Study

B. Kestenbaum, I. D. de Boer, B. Psaty, 2011, Hypertension.

Fasting and Post-Glucose Load Measures of Insulin Resistance and Risk of Ischemic Stroke in Older Adults

I. D. de Boer, B. Psaty, D. Siscovick, 2011, Stroke.

Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women.

D. Mozaffarian, L. Kuller, I. D. de Boer, 2011, American journal of epidemiology.

Chronic kidney disease attenuates the plasma metabolome response to insulin.

B. Kestenbaum, I. D. de Boer, S. Kahn, 2018, JCI insight.

Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.

A. Paterson, B. Zinman, I. D. de Boer, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Pulmonary surfactant protein B carried by HDL predicts incident CVD in patients with type 1 diabetes

W. S. Davidson, I. D. de Boer, J. Snell-Bergeon, 2022, Journal of lipid research.

Incidence and Risk Factors for Postcontrast Acute Kidney Injury in Survivors of Sudden Cardiac Arrest.

P. Kudenchuk, I. D. de Boer, M. Gunn, 2016, Annals of emergency medicine.

Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease

I. D. de Boer, I. Hirsch, J. Himmelfarb, 2014, Physiological reports.

Circulating vitamin D metabolites and kidney disease in type 1 diabetes.

B. Zinman, I. D. de Boer, A. Hoofnagle, 2012, The Journal of clinical endocrinology and metabolism.

Changes in vitamin D-related mineral metabolism after induction with anti-tumor necrosis factor-α therapy in Crohn's disease.

R. Baldassano, I. D. de Boer, J. Shults, 2014, The Journal of clinical endocrinology and metabolism.

Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2017, The Journal of clinical endocrinology and metabolism.

Carotid Artery Stiffness Mechanisms Are Associated With End Organ Damage and All‐Cause Mortality: MESA (Multi‐Ethnic Study of Atherosclerosis)

B. Kestenbaum, I. D. de Boer, S. Heckbert, 2023, Journal of the American Heart Association.

Optimal Frequency of Urinary Albumin Screening in Type 1 Diabetes.

B. Zinman, I. D. de Boer, D. Nathan, 2022, Diabetes care.

Creatinine clearance, walking speed, and muscle atrophy: a cohort study.

L. Ferrucci, B. Kestenbaum, C. Robinson-Cohen, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

25-Hydroxyvitamin D and Parathyroid Hormone Are Not Associated With Carotid Intima-Media Thickness or Plaque in the Multi-Ethnic Study of Atherosclerosis

J. Kaufman, B. Kestenbaum, I. D. de Boer, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Null association between abdominal muscle and calcified atherosclerosis in community-living persons without clinical cardiovascular disease: the multi-ethnic study of atherosclerosis.

M. Budoff, I. D. de Boer, M. Criqui, 2013, Metabolism: clinical and experimental.

Invited Perspective: Still Hazy? Air Pollution and Acute Kidney Injury

I. D. de Boer, Simon Hsu, Jianzhao Bi, 2023, Environmental health perspectives.

Bone mineral density and long-term progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis.

M. Budoff, B. Kestenbaum, I. D. de Boer, 2021, Atherosclerosis.

The multi-ethnic study of atherosclerosis individual response to vitamin D trial: Building a randomized clinical trial into an observational cohort study.

K. Watson, B. Kestenbaum, I. D. de Boer, 2021, Contemporary clinical trials.

Race, Ancestry and Vitamin D Metabolism: The Multi-Ethnic Study of Atherosclerosis.

K. Watson, B. Kestenbaum, C. Robinson-Cohen, 2020, The Journal of clinical endocrinology and metabolism.

Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Fibroblast Growth Factor-23 and Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS)

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2014, Circulation.

Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2009, Kidney international.

Young Kidney Professionals' Perspectives and Attitudes about Consuming Scientific Information: A Focus Group Study.

Jane O. Schell, I. D. de Boer, A. Tong, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

J. Polak, B. Kestenbaum, I. D. de Boer, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.

A. Go, I. D. de Boer, M. Wolf, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 Diabetes

T. Ahluwalia, I. D. de Boer, L. Natarajan, 2020, American Journal of Nephrology.

Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.

B. Kestenbaum, I. D. de Boer, N. Bansal, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2013, The Journal of clinical endocrinology and metabolism.

Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update

K. Khunti, I. D. de Boer, M. Tonelli, 2023, Annals of Internal Medicine.

Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.

B. Zinman, I. D. de Boer, C. Cowie, 2018, Diabetes care.

Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.

A. Go, Mahboob Rahman, I. D. de Boer, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Individualizing Blood Pressure Targets for People With Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations.

C. Cannon, I. D. de Boer, G. Bakris, 2018, JAMA.

Serum Phosphate and Retinal Microvascular Changes: The Multi-Ethnic Study of Atherosclerosis and the Beaver Dam Eye Study

R. Klein, T. Wong, B. Kestenbaum, 2017, Ophthalmic epidemiology.

The 24,25 to 25-hydroxyvitamin D ratio and fracture risk in older adults: The cardiovascular health study.

B. Kestenbaum, I. D. de Boer, A. Hoofnagle, 2018, Bone.

Associations of Vitamin D–Binding Globulin and Bioavailable Vitamin D Concentrations With Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA)

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2017, The Journal of clinical endocrinology and metabolism.

Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes

G. Michailidis, T. Ahluwalia, I. D. de Boer, 2021, Diabetes Care.

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease

I. D. de Boer, I. Hirsch, N. Bansal, 2020, BMJ Open Diabetes Research & Care.

HDL in CKD: how good is the "good cholesterol?".

I. D. de Boer, J. Brunzell, 2014, Journal of the American Society of Nephrology : JASN.

25-Hydroxyvitamin D Concentration and Sleep Duration and Continuity: Multi-Ethnic Study of Atherosclerosis.

M. Szklo, I. D. de Boer, S. Redline, 2015, Sleep.

Circulating Vitamin D Metabolites and Subclinical Atherosclerosis in Type 1 Diabetes

B. Zinman, I. D. de Boer, A. Hoofnagle, 2013, Diabetes Care.

Impaired Glucose and Insulin Homeostasis in Moderate-Severe CKD.

B. Kestenbaum, I. D. de Boer, T. Ikizler, 2016, Journal of the American Society of Nephrology : JASN.

Markers of mineral metabolism are not associated with aortic pulse wave velocity in community-living elderly persons: the Health Aging and Body Composition study.

I. D. de Boer, S. Kritchevsky, A. Newman, 2011, American journal of hypertension.

Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis).

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2014, Journal of the American College of Cardiology.

Serum Vitamin D: Correlates of Baseline Concentration and Response to Supplementation in VITAL-DKD.

J. Manson, N. Cook, J. Buring, 2021, The Journal of clinical endocrinology and metabolism.

Association of cardiovascular disease risk factors with coronary artery calcium volume versus density

B. Kestenbaum, I. D. de Boer, P. Greenland, 2017, Heart.

Relation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the Cardiovascular Health Study).

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2013, The American journal of cardiology.

Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Effects of Serum Creatinine Calibration on Estimated Renal Function in African Americans: The Jackson Heart Study

I. D. de Boer, A. Correa, M. Griswold, 2015, The American journal of the medical sciences.

Association of Muscle Endurance, Fatigability, and Strength With Functional Limitation and Mortality in the Health Aging and Body Composition Study

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults.

Lorien S. Dalrymple, B. Kestenbaum, I. D. de Boer, 2017, Journal of the American Society of Nephrology : JASN.

Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study.

B. Kestenbaum, I. D. de Boer, L. Carbone, 2013, The Journal of clinical endocrinology and metabolism.

Rates of Cardiac Rhythm Abnormalities in Patients with CKD and Diabetes.

I. D. de Boer, I. Hirsch, N. Bansal, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Role of endogenous adenine in kidney failure and mortality with diabetes

B. Kestenbaum, I. D. de Boer, S. Waikar, 2023, medRxiv.

Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study.

L. Kuller, I. D. de Boer, R. Mackey, 2016, Metabolism: clinical and experimental.

Mineral Metabolism Disturbances and Arteriovenous Fistula Maturation.

G. Beck, A. Cheung, B. Kestenbaum, 2019, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial.

J. Manson, J. Buring, R. Glynn, 2019, JAMA.

DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes

Angelo J. Canty, J. Keith Jones, A. Paterson, 2020, Clinical Epigenetics.

Gender and elevated albumin excretion in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: role of central obesity.

I. D. de Boer, M. Steffes, J. Brunzell, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD.

S. Cummings, I. D. de Boer, S. Kritchevsky, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial.

S. Mudaliar, J. McGill, I. D. de Boer, 2023, JAMA internal medicine.

Determinants of mobility decline in nephrology-referred patients with CKD: a longitudinal cohort study

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2022, medRxiv.

Serum Parathyroid Hormone and 25‐Hydroxyvitamin D Concentrations and Risk of Incident Heart Failure: The Multi‐Ethnic Study of Atherosclerosis

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2014, Journal of the American Heart Association.

Serum 25-Hydroxyvitamin D Concentrations Are Associated with Computed Tomography Markers of Subclinical Interstitial Lung Disease among Community-Dwelling Adults in the Multi-Ethnic Study of Atherosclerosis (MESA).

R. Barr, B. Kestenbaum, I. D. de Boer, 2018, The Journal of nutrition.

Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease.

I. D. de Boer, R. Mehrotra, M. Afkarian, 2016, Journal of diabetes and its complications.

Parity and the Association With Diabetes in Older Women

L. Kuller, I. D. de Boer, D. Siscovick, 2010, Diabetes Care.

Heterogeneous treatment effects of intensive glycemic control on kidney microvascular outcomes in ACCORD

I. D. de Boer, G. Chertow, M. Montez-Rath, 2023, medRxiv.

Hypoglycemia in People with Type 2 Diabetes and CKD.

I. D. de Boer, I. Hirsch, N. Bansal, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Effects of long-term vitamin D and n-3 fatty acid supplementation on inflammatory and cardiac biomarkers in patients with type 2 diabetes: secondary analyses from a randomised controlled trial

J. Manson, J. Buring, I. D. de Boer, 2020, Diabetologia.

Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.

M. Budoff, B. Kestenbaum, I. D. de Boer, 2016, Atherosclerosis.

Common genetic determinants of vitamin D insufficiency: a genome-wide association study

Daniel L. Koller, P. O’Reilly, D. Kiel, 2010, The Lancet.

Plasma vitamin D is associated with fasting insulin and homeostatic model assessment of insulin resistance in young adult males, but not females, of the Jerusalem Perinatal Study

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2014, Public Health Nutrition.

Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis.

K. W. Davidson, J. Gallacher, J. Danesh, 2012, International journal of epidemiology.

Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study

J. Keith Jones, A. Paterson, S. Mudaliar, 2018, Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease.

Chronic kidney disease and obesity bias surrogate estimates of insulin sensitivity compared with the hyperinsulinemic euglycemic clamp.

B. Kestenbaum, I. D. de Boer, A. Hung, 2017, American journal of physiology. Endocrinology and metabolism.

Tubular Secretory Clearance is Associated with Whole-Body Insulin Clearance.

B. Kestenbaum, I. D. de Boer, S. Kahn, 2020, The Journal of clinical endocrinology and metabolism.

Prediction of Kidney Drug Clearance: A Comparison of Tubular Secretory Clearance and Glomerular Filtration Rate.

Brian R. Phillips, B. Kestenbaum, I. D. de Boer, 2020, Journal of the American Society of Nephrology : JASN.

Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes

I. D. de Boer, G. Bakris, 2018, Diabetes Care.

Vitamin D supplementation in people with CKD.

I. D. de Boer, M. Vervloet, Simon Hsu, 2023, Kidney international.

Clinical and biomarker modifiers of vitamin D treatment response: the multi-ethnic study of atherosclerosis.

K. Watson, B. Kestenbaum, I. D. de Boer, 2021, The American journal of clinical nutrition.

Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes.

T. Ahluwalia, I. D. de Boer, L. Natarajan, 2022, Diabetes care.

The Case for Early Identification and Intervention of Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Jenny I. Shen, N. Powe, I. D. de Boer, 2020, Kidney international.

Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2012, Journal of the American College of Cardiology.

Fibroblast growth factor-23 and the long-term risk of hospital-associated AKI among community-dwelling older individuals.

Jeremiah R. Brown, I. D. de Boer, D. Siscovick, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes.

B. Zinman, I. D. de Boer, I. Hirsch, 2022, Diabetes Care.

Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease

Brian J. Bennett, B. Kestenbaum, I. D. de Boer, 2023, JCI insight.

Screening for Chronic Kidney Disease

I. D. de Boer, U. Patel, R. Francis, 2012 .

CKD Associates with Cognitive Decline in Middle-Aged and Older Adults with Long-Standing Type 1 Diabetes

I. D. de Boer, J. Lachin, C. Ryan, 2023, Kidney360.

Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2023, Journal of the American Heart Association.

Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).

Connie M. Rhee, K. Khunti, I. D. de Boer, 2022, Kidney international.

Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients

B. Kestenbaum, I. D. de Boer, L. Natarajan, 2023, The Journal of clinical investigation.

Self-rated health and adverse events in CKD.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2014, Clinical journal of the American Society of Nephrology : CJASN.

High-Density Lipoprotein Lipidomics and Mortality in CKD

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2023, Kidney medicine.

Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2015, The Journal of clinical endocrinology and metabolism.

Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2013, JAMA.

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.

S. Bandinelli, L. Ferrucci, B. Kestenbaum, 2012, JAMA.

Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2012, Journal of the American College of Cardiology.

Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2011, Journal of the American College of Cardiology.

Polymorphic Human Sulfotransferase 2A1 Mediates the Formation of 25-Hydroxyvitamin D3-3-O-Sulfate, a Major Circulating Vitamin D Metabolite in Humans

I. D. de Boer, T. Thornton, E. Schuetz, 2018, Drug Metabolism And Disposition.

Relation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the Cardiovascular Health Study).

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2013, American Journal of Cardiology.

Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study).

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2009, Journal of the American College of Cardiology.

NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.

Lorien S. Dalrymple, B. Kestenbaum, I. D. de Boer, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Cystatin C identifies chronic kidney disease patients at higher risk for complications.

I. D. de Boer, D. Siscovick, A. Levey, 2011, Journal of the American Society of Nephrology : JASN.

The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2012, Kidney international.

Association of fibroblast growth factor-23 with arterial stiffness in the Multi-Ethnic Study of Atherosclerosis.

B. Kestenbaum, I. D. de Boer, M. Shlipak, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Apolipoprotein E and kidney function in older adults

I. D. de Boer, D. Siscovick, M. Shlipak, 2012, Clinical nephrology.

Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D‐Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes

I. D. de Boer, H. Feldman, A. Hoofnagle, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Self-rated health and adverse events in CKD.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Validated SNPs for eGFR and their associations with albuminuria.

A. Köttgen, C. Fox, I. D. de Boer, 2012, Human molecular genetics.

Obesity and change in estimated GFR among older adults.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Genetic Variants Associated with Mineral Metabolism Traits in Chronic Kidney Disease.

P. A. Friedman, B. Kestenbaum, C. Robinson-Cohen, 2022, The Journal of clinical endocrinology and metabolism.

25-Hydroxyvitamin D and Parathyroid Hormone Levels Do Not Predict Changes in Carotid Arterial Stiffness: The Multi-Ethnic Study of Atherosclerosis

J. Kaufman, B. Kestenbaum, I. D. de Boer, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Creatinine clearance, walking speed, and muscle atrophy: a cohort study.

L. Ferrucci, B. Kestenbaum, C. Robinson-Cohen, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis.

M. Szklo, I. D. de Boer, D. O'leary, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Association of body mass index with peripheral arterial disease in older adults: the Cardiovascular Health Study.

I. D. de Boer, D. Siscovick, M. Criqui, 2011, American journal of epidemiology.

Chronic kidney disease attenuates the plasma metabolome response to insulin.

B. Kestenbaum, I. D. de Boer, S. Kahn, 2018, JCI insight.

Association between adiposity in midlife and older age and risk of diabetes in older adults.

D. Mozaffarian, I. D. de Boer, D. Siscovick, 2010, JAMA.

Diabetes and CKD in the United States Population, 2009-2014.

P. Heagerty, B. Kestenbaum, C. Robinson-Cohen, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study.

B. Kestenbaum, I. D. de Boer, D. Siscovick, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Continuous Glucose Monitoring: A Rapidly Evolving New Tool to Understand Pathophysiology and Enhance Clinical Care in CKD.

I. D. de Boer, I. Hirsch, 2023, Clinical journal of the American Society of Nephrology : CJASN.

Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - a post-hoc analysis of the PERL study.

J. McGill, I. D. de Boer, T. Hansen, 2022, Diabetes research and clinical practice.

Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes

I. D. de Boer, I. Hirsch, S. Waikar, 2023, Clinical journal of the American Society of Nephrology : CJASN.